Trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
 does an outstanding job discussing destiny crc study and educating us about all anti-her2 therapies in mcrc. #asco23
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded